Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Signal Transduction and Targeted Therapy|March 14, 2022
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editingZiwen Zheng, Guo Li, Chong Cui, et al.Research (Washington, D.C.)|April 26, 2024
Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner EarShao Wei Hu, Jun Lv, Zijing Wang, et al.Nature Communications|May 25, 2023
Asymmetric pendrin homodimer reveals its molecular mechanism as anion exchangerQianying Liu, Xiang Zhang, Hui Huang, et al.Nature Biomedical Engineering|August 12, 2024
A base editor for the long-term restoration of auditory function in mice with recessive profound deafnessChong Cui, Shengyi Wang, Daqi Wang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2021
Gene editing in a Myo6 semi-dominant mouse model rescues auditory functionYuanyuan Xue, Xinde Hu, Daqi Wang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 2, 2023
RNA base editing therapy cures hearing loss induced by OTOF gene mutationYuanyuan Xue, Yong Tao, Xing Wang, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 13, 2020
Approaching Otolaryngology Patients During the COVID-19 PandemicChong Cui, Qi Yao, Di Zhang, et al.Nature Communications|August 15, 2023
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoYong Tao, Veronica Lamas, Wan Du, et al.Frontiers in Public Health|June 24, 2020
COVID19: A Systematic Approach to Early Identification and Healthcare Worker ProtectionYu Zhao, Chong Cui, Kun Zhang, et al.Nature|December 21, 2017
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agentsXue Gao, Yong Tao, Veronica Lamas, et al.Pageof 13